SLC13A5	O
is	O
a	O
novel	O
transcriptional	O
target	O
of	O
the	O
pregnane	O
X	O
receptor	O
and	O
sensitizes	O
drug	O
-	O
induced	O
steatosis	O
in	O
human	S-SPECIES
liver	O
.	O


The	O
solute	O
carrier	O
family	O
13	O
member	O
5	O
(	O
SLC13A5	O
)	O
is	O
a	O
sodium	O
-	O
coupled	O
transporter	O
that	O
mediates	O
cellular	O
uptake	O
of	O
citrate	O
,	O
which	O
plays	O
important	O
roles	O
in	O
the	O
synthesis	O
of	O
fatty	O
acids	O
and	O
cholesterol	O
.	O


Recently	O
,	O
the	O
pregnane	O
X	O
receptor	O
(	O
PXR	O
,	O
NR1I2	O
)	O
,	O
initially	O
characterized	O
as	O
a	O
xenobiotic	O
sensor	O
,	O
has	O
been	O
functionally	O
linked	O
to	O
the	O
regulation	O
of	O
various	O
physiologic	O
processes	O
that	O
are	O
associated	O
with	O
lipid	O
metabolism	O
and	O
energy	O
homeostasis	O
.	O


Here	O
,	O
we	O
show	O
that	O
the	O
SLC13A5	O
gene	O
is	O
a	O
novel	O
transcriptional	O
target	O
of	O
PXR	O
,	O
and	O
altered	O
expression	O
of	O
SLC13A5	O
affects	O
lipid	O
accumulation	O
in	O
human	S-SPECIES
liver	O
cells	O
.	O


The	O
prototypical	O
PXR	O
activator	O
rifampicin	O
markedly	O
induced	O
the	O
mRNA	O
and	O
protein	O
expression	O
of	O
SLC13A5	O
in	O
human	S-SPECIES
primary	O
hepatocytes	O
.	O


Utilizing	O
cell	O
-	O
based	O
luciferase	O
reporter	O
assays	O
,	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
and	O
chromatin	O
immunoprecipitation	O
assays	O
,	O
we	O
identified	O
and	O
functionally	O
characterized	O
two	O
enhancer	O
modules	O
located	O
upstream	O
of	O
the	O
SLC13A5	O
gene	O
transcription	O
start	O
site	O
that	O
are	O
associated	O
with	O
regulation	O
of	O
PXR	O
-	O
mediated	O
SLC13A5	O
induction	O
.	O


Functional	O
analysis	O
further	O
revealed	O
that	O
rifampicin	O
can	O
enhance	O
lipid	O
accumulation	O
in	O
human	S-SPECIES
primary	O
hepatocytes	O
,	O
and	O
knockdown	O
of	O
SLC13A5	O
expression	O
alone	O
leads	O
to	O
a	O
significant	O
decrease	O
of	O
the	O
lipid	O
content	O
in	O
HepG2	O
cells	O
.	O


Overall	O
,	O
our	O
results	O
uncover	O
SLC13A5	O
as	O
a	O
novel	O
target	O
gene	O
of	O
PXR	O
and	O
may	O
contribute	O
to	O
drug	O
-	O
induced	O
steatosis	O
and	O
metabolic	O
disorders	O
in	O
humans	S-SPECIES
.	O
